Mail

UK markets closed

FTSE 100
8,275.38
+44.33(+0.54%)
FTSE 250
20,730.12
+59.25(+0.29%)
AIM
805.79
+3.10(+0.39%)
GBP/EUR
1.1742
-0.0007(-0.06%)
GBP/USD
1.2738
+0.0006(+0.05%)
Bitcoin GBP
53,184.32
+277.46(+0.52%)

10 bijou homes that are big on style

Size isn’t everything when it comes to buying a home

Mineralys Therapeutics, Inc. (MLYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

12.77

+0.35

(+2.82%)

At close: 04:00PM EDT

12.77

0.00

(0.00%)

After hours:

04:03PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	635.00M
Enterprise value	638.10M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.94
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-24.25

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-12.59%
S&P500 52-week change ³	23.49%
52-week high ³	17.44
52-week low ³	5.85
50-day moving average ³	12.67
200-day moving average ³	10.89

Share statistics

Avg vol (3-month) ³	132.62k
Avg vol (10-day) ³	75.69k
Shares outstanding ⁵	49.65M
Implied shares outstanding ⁶	49.65M
Float ⁸	23M
% held by insiders ¹	2.98%
% held by institutions ¹	95.95%
Shares short (15 May 2024) ⁴	949.71k
Short ratio (15 May 2024) ⁴	6.03
Short % of float (15 May 2024) ⁴	2.80%
Short % of shares outstanding (15 May 2024) ⁴	1.91%
Shares short (prior month 15 Apr 2024) ⁴	872.86k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-20.09%
Return on equity (ttm)	-29.11%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-90.8M
Diluted EPS (ttm)	-2.18
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	338.56M
Total cash per share (mrq)	6.82
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	18.06
Book value per share (mrq)	6.61

Cash flow statement

Operating cash flow (ttm)	-87.54M
Levered free cash flow (ttm)	-54.2M